Home › Trial NCT04282031
A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer
- Trial IDNCT04282031
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorBeta Pharma (Suzhou) Co., Ltd.
- Enrollment224
- Start date2020-06-15
- ConditionsAdvanced Solid Tumor · HR+/HER2- Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.